Dare Bioscience, Inc. - Common Stock (DARE)
2.8400
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 16th, 6:56 AM EDT
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · July 15, 2025
Via Benzinga · July 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Unusual volume stocks in Monday's session
Via Chartmill · July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 11, 2025

Via Benzinga · June 4, 2025

DARE stock results show that Dare Bioscience beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · May 21, 2024

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
Via Benzinga · May 17, 2024

DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024